Divence Tetra RSSAuthorisedThis medicine is authorised for use in the European Unionbovine viral diarrhoea virus type 1 and type 2 (subunit recombinant) / bovine parainfluenza 3 virus (inactivated) and bovine respiratory syncytial virus vaccineMedicineVeterinaryAuthorised
Page contents OverviewProduct detailsAuthorisation detailsAssessment historyNews on Divence TetraApplication under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Divence Tetra Active substance bovine viral diarrhoea virus type 1 and type 2 (subunit recombinant)bovine parainfluenza 3 virus (inactivated) and bovine respiratory syncytial virus vaccine International non-proprietary name (INN) or common name bovine viral diarrhoea virus type 1 and type 2 (subunit recombinant)bovine parainfluenza 3 virus (inactivated) and bovine respiratory syncytial virus vaccinePharmacotherapeutic groupImmunologicals for BovidaeLive and inactivated viral vaccinesAuthorisation details EMA product number EMEA/V/C/006222 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for Divence TetraAdoptedReference Number: EMA/CVMP/98737/2024 English (EN) (139.96 KB - PDF)First published: 18/03/2024ViewNews on Divence TetraMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-13 March 202418/03/2024This page was last updated on 31/05/2024Share this page